The editorial suggests that it may help to think of GLP-1 drugs like other medications for chronic conditions
Most obesity medicine specialists consider the risk-benefit ratio unfavorable when safer, evidence-based alternatives exist
187 Reduction of insulin levels with diazoxide Diazoxide is a nondiuretic benzothiadiazine that has an antihypertensive effect and produces hyperglycemia via lowering insulin levels by activation of ATP-sensitive K + -channels, which have a key function in the control of insulin release
The two most popular options, semaglutide and tirzepatide , have different mechanisms and produce somewhat different transformation patterns
Porokhovnik LN, cape BM, yaeo A, Chudakova YuM, Ershova ES, Veiko NN, Gorbachevskaya NL, Mamokhina U, Sorokin A, Basova AY, Lapshin MS, Izhevskaya VL, Kostyuk SV (2023) Association of NEF2L2 Rs35652124 polymorphism with Nrf2 induction and genotoxic stress biomarkers in autism
x , AUC of w